Acasti Pharma changes name to Grace Therapeutics
Slightly above 67% of ACST Old's investor base is looking to short. The analysis of current outlook of investing in ACST Old suggests that many traders are alarmed regarding ACST Old's prospects. ACST Old's investing sentiment can be driven by a variety of factors including economic data, ACST Old's earnings reports, geopolitical events, and overall market trends.
ACST |
Acasti Pharma changes its name to Grace Therapeutics, set to trade as GRCE on Nasdaq starting October 28, 2024.
Read at seekingalpha.com
![]() |
ACST Old Fundamental Analysis
We analyze ACST Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ACST Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ACST Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
ACST Old is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
ACST Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ACST Old stock to make a market-neutral strategy. Peer analysis of ACST Old could also be used in its relative valuation, which is a method of valuing ACST Old by comparing valuation metrics with similar companies.
Peers
ACST Old Related Equities
IBIO | Ibio | 15.45 | ||||
JAGX | Jaguar Animal | 6.90 | ||||
OCGN | Ocugen | 6.56 | ||||
PULM | Pulmatrix | 4.66 | ||||
MBRX | Moleculin Biotech | 1.57 | ||||
GOVX | GeoVax Labs | 2.70 | ||||
AKTX | Akari Therapeutics | 3.33 | ||||
TNXP | Tonix Pharmaceuticals | 3.91 | ||||
BPTH | Bio Path | 5.00 | ||||
ABVC | ABVC Biopharma | 13.75 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in ACST Stock
If you are still planning to invest in ACST Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ACST Old's history and understand the potential risks before investing.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |